Devan Elayna Scott, APRN

Devan Scott practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Devan Scott's NPI, 1932812435, was assigned on December 29, 2022. Devan Scott holds Texas license 1103071.

Devan Scott's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Devan Scott's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Devan Scott practices. Vendor and product names are available with a free account.

Gerontology is Devan Scott's primary specialty in the NPI Registry, under taxonomy code 363LG0600X. Devan Scott is licensed in Texas.

CMS counts 118 Medicare patients who saw Devan Scott in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 9% are also on Medicaid. Their average risk score is 3.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Devan Scott's median patient age at 67, with 48% women.

In 2024, Devan Scott wrote 13 Medicare Part D claims. 100% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Devan Scott for performance year 2024, reported as part of a group. Devan Scott accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 13 general payments to Devan Scott from 8 drug and device companies in 2025. Food and beverage make up the largest share, 77% of the total. Syndax Pharmaceuticals, Inc. paid the most, $157.